BZ-068

N/A

Report date: 2025/05/23 16:52:39
NME

Base Information

Drug NameBZ-068
Drug Alias NameBZ-068
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factors modulatorsT lymphocytes inhibitors
TargetsFibroblast growth factors
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiozeus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiozeus
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A